TrialHuman vaccines & immunotherapeutics2022

A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults.

Kevin L Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.